REGISTERED NUMBER: 11601433 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 October 2025

for

Mediprotect Healthcare Limited

Page

Balance Sheet

1

Notes to the Financial Statements

2

FIXED ASSETS

Tangible assets

4

401

535

CURRENT ASSETS

Debtors

5

14,001

70,000

Cash at bank

60,541

41,445

74,542

111,445

CREDITORS

Amounts falling due within one year

6

47,291

63,561

NET CURRENT ASSETS

27,251

47,884

TOTAL ASSETS LESS CURRENT LIABILITIES

27,652

48,419

CREDITORS

Amounts falling due after more than one year

7

-

(16,056

)

PROVISIONS FOR LIABILITIES

(100

)

(134

)

NET ASSETS

27,552

32,229

CAPITAL AND RESERVES

Called up share capital

100

100

Retained earnings

27,452

32,129

SHAREHOLDERS' FUNDS

27,552

32,229

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30 June 2026 and were signed on its behalf by:

Mr E G F Hannan - Director

1.	STATUTORY INFORMATION

Mediprotect Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

11601433

Registered office:

Coversure House Vantage Park

Washingley Road

Huntingdon

Cambridgeshire

PE29 6SR

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue is recognised as the company becomes entitled to consideration for the goods and services supplied. Therefore, turnover also includes the element of work completed but not yet invoiced on service contracts.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings

-

25% on reducing balance

Computer equipment

-

33% on cost

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - 2 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

and

Computer

fittings

equipment

Totals

£

£

£

COST

At 1 November 2024

and 31 October 2025

1,496

2,050

3,546

DEPRECIATION

At 1 November 2024

961

2,050

3,011

Charge for year

134

-

134

At 31 October 2025

1,095

2,050

3,145

NET BOOK VALUE

At 31 October 2025

401

-

401

At 31 October 2024

535

-

535

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Other debtors

14,001

70,000

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Taxation and social security

43,727

54,282

Other creditors

3,564

9,279

47,291

63,561

7.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2025

2024

£

£

Other creditors

-

16,056

8.	DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 October 2025 and 31 October 2024:

2025

2024

£

£

Mr J J Legge

Balance outstanding at start of year

(78

)

18,930

Amounts advanced

146,949

7,641

Amounts repaid

(146,871

)

(26,649

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

-

(78

)

Mr J M Brittain

Balance outstanding at start of year

-

16,867

Amounts repaid

-

(16,867

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

-

-

9.	POST BALANCE SHEET EVENTS

On 17th October 2025, the company entered into an agreement to sell the shares. The sale was completed on 15th December 2025.

The business was active until the date of sale, and as such, no adjustments to the valuation of assets or liabilities have been made in these financial statements as at 31st October 2025.